| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 18 | 2023 | 1022 | 4.710 |
Why?
|
| DNA-Binding Proteins | 22 | 2023 | 2056 | 3.960 |
Why?
|
| E2F1 Transcription Factor | 13 | 2020 | 48 | 3.230 |
Why?
|
| Nuclear Proteins | 17 | 2023 | 1271 | 2.870 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2023 | 719 | 2.330 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2021 | 357 | 2.220 |
Why?
|
| 14-3-3 Proteins | 5 | 2022 | 54 | 2.150 |
Why?
|
| Cell Cycle Proteins | 10 | 2021 | 645 | 1.680 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 2489 | 1.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2022 | 488 | 1.470 |
Why?
|
| DNA Damage | 12 | 2021 | 515 | 1.450 |
Why?
|
| Apoptosis | 11 | 2014 | 1791 | 1.390 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 410 | 1.230 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2023 | 30 | 1.090 |
Why?
|
| Ubiquitination | 5 | 2021 | 174 | 1.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 6 | 2021 | 94 | 1.010 |
Why?
|
| DNA Repair | 4 | 2021 | 583 | 0.990 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2019 | 470 | 0.980 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 213 | 0.940 |
Why?
|
| DNA Replication | 5 | 2021 | 350 | 0.920 |
Why?
|
| Cell Line, Tumor | 13 | 2022 | 3329 | 0.900 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 259 | 0.880 |
Why?
|
| Phosphorylation | 15 | 2021 | 1623 | 0.850 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2020 | 50 | 0.840 |
Why?
|
| Checkpoint Kinase 1 | 3 | 2021 | 24 | 0.830 |
Why?
|
| GATA3 Transcription Factor | 1 | 2022 | 39 | 0.820 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 2535 | 0.820 |
Why?
|
| Promoter Regions, Genetic | 7 | 2019 | 1340 | 0.810 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 553 | 0.780 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 29 | 0.750 |
Why?
|
| Protein Binding | 11 | 2020 | 1748 | 0.730 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 109 | 0.710 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 355 | 0.690 |
Why?
|
| Transcription Factors | 10 | 2021 | 2596 | 0.690 |
Why?
|
| Down-Regulation | 4 | 2012 | 698 | 0.670 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 234 | 0.660 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2021 | 548 | 0.650 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 459 | 0.630 |
Why?
|
| Actins | 1 | 2021 | 343 | 0.620 |
Why?
|
| Carcinogenesis | 1 | 2021 | 327 | 0.610 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 54 | 0.610 |
Why?
|
| HEK293 Cells | 7 | 2015 | 744 | 0.600 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 121 | 0.590 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 551 | 0.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2022 | 1890 | 0.580 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1701 | 0.540 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 721 | 0.530 |
Why?
|
| Ubiquitin | 3 | 2012 | 142 | 0.510 |
Why?
|
| Cell Cycle | 6 | 2020 | 619 | 0.510 |
Why?
|
| S Phase | 5 | 2020 | 73 | 0.510 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 656 | 0.500 |
Why?
|
| Cell Line | 11 | 2020 | 2779 | 0.500 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 483 | 0.500 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 62 | 0.490 |
Why?
|
| Mutation, Missense | 2 | 2017 | 869 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 528 | 0.490 |
Why?
|
| Oxidative Stress | 1 | 2020 | 814 | 0.470 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2014 | 10 | 0.470 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2014 | 18 | 0.460 |
Why?
|
| Humans | 40 | 2023 | 124083 | 0.460 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 68 | 0.450 |
Why?
|
| Mice | 20 | 2021 | 17716 | 0.450 |
Why?
|
| Catalytic Domain | 1 | 2014 | 157 | 0.440 |
Why?
|
| Cell Membrane | 1 | 2015 | 458 | 0.430 |
Why?
|
| Cell Proliferation | 2 | 2018 | 2305 | 0.430 |
Why?
|
| Signal Transduction | 5 | 2021 | 4520 | 0.430 |
Why?
|
| Membrane Proteins | 2 | 2011 | 1527 | 0.420 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 28 | 0.400 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 151 | 0.390 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 6 | 0.390 |
Why?
|
| Animals | 22 | 2023 | 34094 | 0.380 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 657 | 0.380 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2013 | 265 | 0.370 |
Why?
|
| Cadherins | 1 | 2012 | 164 | 0.370 |
Why?
|
| Chromatin | 3 | 2021 | 556 | 0.370 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1601 | 0.360 |
Why?
|
| RNA, Small Interfering | 7 | 2012 | 671 | 0.360 |
Why?
|
| G1 Phase | 5 | 2011 | 67 | 0.340 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 82 | 0.340 |
Why?
|
| Amino Acid Substitution | 3 | 2017 | 393 | 0.340 |
Why?
|
| DNA Helicases | 2 | 2023 | 225 | 0.320 |
Why?
|
| Receptors, Lysophosphatidic Acid | 2 | 2007 | 10 | 0.310 |
Why?
|
| Amino Acid Motifs | 2 | 2020 | 199 | 0.290 |
Why?
|
| ErbB Receptors | 2 | 2019 | 287 | 0.290 |
Why?
|
| Heterografts | 2 | 2019 | 178 | 0.270 |
Why?
|
| Autophagy | 1 | 2010 | 393 | 0.270 |
Why?
|
| Protein Isoforms | 2 | 2022 | 410 | 0.270 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2019 | 138 | 0.270 |
Why?
|
| Doxorubicin | 5 | 2008 | 301 | 0.260 |
Why?
|
| Lysophospholipids | 4 | 2007 | 30 | 0.260 |
Why?
|
| Cisplatin | 3 | 2021 | 243 | 0.260 |
Why?
|
| Proteins | 5 | 1996 | 1042 | 0.260 |
Why?
|
| Tamoxifen | 2 | 2022 | 363 | 0.260 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 5 | 2021 | 67 | 0.250 |
Why?
|
| Female | 11 | 2023 | 66156 | 0.250 |
Why?
|
| Gene Expression | 2 | 2021 | 1569 | 0.250 |
Why?
|
| Protein Kinases | 3 | 2021 | 332 | 0.250 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 21 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 1289 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 618 | 0.230 |
Why?
|
| DNA Repair Enzymes | 1 | 2004 | 40 | 0.230 |
Why?
|
| Antigens, CD | 2 | 2012 | 421 | 0.220 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2023 | 8 | 0.220 |
Why?
|
| E2F Transcription Factors | 4 | 2004 | 24 | 0.220 |
Why?
|
| Endonucleases | 1 | 2023 | 54 | 0.220 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 208 | 0.210 |
Why?
|
| Neoplasms | 3 | 2014 | 2781 | 0.210 |
Why?
|
| Mice, Nude | 3 | 2014 | 696 | 0.210 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 112 | 0.210 |
Why?
|
| Genes, p53 | 1 | 2023 | 213 | 0.210 |
Why?
|
| Survival Analysis | 2 | 2021 | 1478 | 0.200 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 370 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1110 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2011 | 3054 | 0.190 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2021 | 6 | 0.180 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 3 | 1995 | 5 | 0.180 |
Why?
|
| Carcinogens | 1 | 2021 | 153 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 767 | 0.180 |
Why?
|
| DNA Adducts | 1 | 2021 | 78 | 0.180 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 76 | 0.180 |
Why?
|
| Protein Subunits | 2 | 2012 | 164 | 0.180 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 17 | 0.180 |
Why?
|
| Tumor Protein p73 | 2 | 2011 | 22 | 0.170 |
Why?
|
| G2 Phase | 1 | 2020 | 45 | 0.170 |
Why?
|
| Sumoylation | 1 | 2020 | 33 | 0.170 |
Why?
|
| E2F3 Transcription Factor | 3 | 2004 | 11 | 0.170 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 301 | 0.170 |
Why?
|
| RNA Interference | 2 | 2012 | 504 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 669 | 0.170 |
Why?
|
| Trans-Activators | 1 | 2004 | 808 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2021 | 229 | 0.170 |
Why?
|
| NIH 3T3 Cells | 4 | 2007 | 93 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 114 | 0.170 |
Why?
|
| Cyclins | 1 | 2020 | 101 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 754 | 0.170 |
Why?
|
| Thymus Gland | 3 | 2001 | 100 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1064 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 29 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2000 | 100 | 0.160 |
Why?
|
| Transfection | 5 | 2008 | 1068 | 0.160 |
Why?
|
| Herpesvirus 6, Human | 1 | 1999 | 58 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 354 | 0.150 |
Why?
|
| Lymphoma, T-Cell | 1 | 1999 | 64 | 0.150 |
Why?
|
| Cell Division | 1 | 2020 | 784 | 0.150 |
Why?
|
| Protein Transport | 1 | 2019 | 368 | 0.150 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2000 | 193 | 0.150 |
Why?
|
| Mutation | 6 | 2019 | 5790 | 0.150 |
Why?
|
| LIM Domain Proteins | 4 | 2013 | 59 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 1995 | 19 | 0.150 |
Why?
|
| Herpesviridae Infections | 1 | 1999 | 143 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 887 | 0.150 |
Why?
|
| Biological Transport | 1 | 2018 | 346 | 0.150 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1674 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 681 | 0.140 |
Why?
|
| Disease Progression | 2 | 2022 | 2037 | 0.140 |
Why?
|
| Receptors, Antigen | 2 | 1996 | 34 | 0.140 |
Why?
|
| Cell Movement | 4 | 2013 | 834 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1999 | 391 | 0.130 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1995 | 10 | 0.120 |
Why?
|
| Models, Immunological | 1 | 1995 | 35 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 98 | 0.120 |
Why?
|
| Cell Adhesion | 2 | 2014 | 319 | 0.120 |
Why?
|
| CDC2 Protein Kinase | 2 | 2011 | 35 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 1995 | 542 | 0.120 |
Why?
|
| Fluoresceins | 1 | 2014 | 35 | 0.120 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 254 | 0.120 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 68 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2014 | 1107 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 1994 | 519 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 199 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2820 | 0.110 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 221 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 2697 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 3872 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 459 | 0.110 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 40 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 1999 | 634 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1241 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3747 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2019 | 998 | 0.110 |
Why?
|
| DNA Primers | 1 | 2014 | 660 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2013 | 127 | 0.110 |
Why?
|
| Hydroxyurea | 1 | 2013 | 83 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 103 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 59 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 244 | 0.100 |
Why?
|
| Serine | 1 | 2013 | 174 | 0.100 |
Why?
|
| Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 2 | 0.100 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 20 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 605 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 509 | 0.100 |
Why?
|
| Cyclin A | 1 | 2011 | 17 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 69 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 258 | 0.090 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 52 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 1993 | 320 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 172 | 0.090 |
Why?
|
| Beclin-1 | 1 | 2010 | 26 | 0.090 |
Why?
|
| Tenascin | 1 | 2010 | 31 | 0.090 |
Why?
|
| Camptothecin | 1 | 2010 | 76 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 102 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 80 | 0.080 |
Why?
|
| Protein Stability | 1 | 2010 | 165 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2008 | 268 | 0.080 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2010 | 54 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4344 | 0.080 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 30 | 0.080 |
Why?
|
| Cell Survival | 2 | 2010 | 807 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2008 | 314 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 239 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 66 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 133 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 70 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 80 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 211 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 153 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 657 | 0.070 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 48 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 392 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2013 | 676 | 0.070 |
Why?
|
| DNA | 3 | 2004 | 1597 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2006 | 109 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 57 | 0.060 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2004 | 9 | 0.060 |
Why?
|
| MutL Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2006 | 349 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 340 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 98 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 185 | 0.060 |
Why?
|
| Survival Rate | 1 | 2009 | 2016 | 0.060 |
Why?
|
| E2F2 Transcription Factor | 1 | 2003 | 4 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 127 | 0.050 |
Why?
|
| E2F4 Transcription Factor | 1 | 2003 | 9 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 623 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2003 | 68 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 812 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 216 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1461 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 282 | 0.050 |
Why?
|
| Etoposide | 1 | 2001 | 118 | 0.050 |
Why?
|
| Machine Learning | 1 | 2023 | 238 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 388 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 891 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1392 | 0.040 |
Why?
|
| Cladribine | 1 | 1999 | 8 | 0.040 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1999 | 16 | 0.040 |
Why?
|
| CD8 Antigens | 1 | 1999 | 40 | 0.040 |
Why?
|
| VDJ Recombinases | 2 | 1995 | 6 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 717 | 0.040 |
Why?
|
| Bone Marrow | 1 | 1999 | 326 | 0.040 |
Why?
|
| Periodicity | 1 | 1996 | 55 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 1995 | 13 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1995 | 38 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1995 | 105 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 238 | 0.030 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1994 | 16 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2005 | 90 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 447 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1995 | 570 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1993 | 129 | 0.030 |
Why?
|
| Zyxin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1996 | 547 | 0.030 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 17 | 0.030 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2013 | 40 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 63 | 0.030 |
Why?
|
| Cytosol | 1 | 2013 | 160 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 295 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1994 | 804 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1999 | 868 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2010 | 35 | 0.020 |
Why?
|
| Ploidies | 1 | 2010 | 37 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 995 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1994 | 1005 | 0.020 |
Why?
|
| DNA Mismatch Repair | 1 | 2010 | 48 | 0.020 |
Why?
|
| Metallothionein | 1 | 1990 | 14 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 55 | 0.020 |
Why?
|
| Columbidae | 1 | 1990 | 20 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 862 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2013 | 333 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 6434 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 499 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2007 | 50 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1999 | 3045 | 0.020 |
Why?
|
| Tyrosine | 1 | 2005 | 152 | 0.020 |
Why?
|
| Paxillin | 1 | 2003 | 10 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 23 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 24 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 151 | 0.010 |
Why?
|
| Male | 2 | 2000 | 60804 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 158 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 1757 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 514 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 335 | 0.010 |
Why?
|
| Aged | 1 | 2000 | 19349 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 403 | 0.010 |
Why?
|
| Middle Aged | 1 | 1999 | 26316 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 188 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 259 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1993 | 136 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1990 | 103 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 286 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1990 | 113 | 0.010 |
Why?
|
| Zinc | 1 | 1990 | 127 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 343 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 3093 | 0.000 |
Why?
|
| Amino Acids | 1 | 1990 | 663 | 0.000 |
Why?
|